A patient with a history of poorly controlled diabetes presents with symptoms of diabetic neuropathy and retinopathy. Laboratory results indicate an elevated HbA1c, increased serum creatinine, and positive urine microalbumin. Which intervention should the nurse prioritize to address the patient's current complications and prevent progression?

A) Educate the patient on the importance of daily foot care and regular foot examinations.

B) Discuss the potential benefits of starting a GLP-1 receptor agonist with the healthcare provider.

C) Emphasize the need for adherence to a low-sodium, low-protein diet to protect renal function.

D) Arrange for a consultation with a dietitian to create a personalized meal plan emphasizing carbohydrate counting.

A patient with a history of type 2 diabetes presents with symptoms of increasing fatigue, numbness in her feet, blurred vision, frequent urination, and increased thirst. Recent lab results reveal an HbA1c of 9.2%, increased serum creatinine of 1.4 mg/dL, LDL cholesterol of 140 mg/dL, and positive urine microalbumin. Which nursing intervention is most crucial to include in the patient's care plan to address her current symptoms and prevent further complications?

B) Initiate a referral to a dietitian for meal planning to improve glycemic control.

A) Educate the patient on the importance of foot care and regular monofilament testing.

B) Initiate a referral to a dietitian for meal planning to improve glycemic control.

C) Recommend an ophthalmology consultation for evaluation of her diabetic retinopathy.

D) Advise the patient to increase her statin dosage to better manage her LDL levels.

A patient with diabetes presents with persistent fatigue, intermittent chest discomfort, and increased episodes of hypoglycemia. Her laboratory results show an elevated LDL cholesterol and increased urine microalbumin levels. What is the priority nursing intervention to address the patient's current symptoms and complications?

B) Refer the patient to a cardiologist for further evaluation of chest discomfort.

A) Educate the patient on dietary modifications to control blood glucose levels.

B) Refer the patient to a cardiologist for further evaluation of chest discomfort.

C) Initiate a continuous glucose monitoring system to better track blood sugar levels.

D) Adjust the patient's statin therapy to better manage her LDL cholesterol levels.

A patient with type 2 diabetes presents with persistent fatigue, intermittent chest discomfort after exertion, and frequent hypoglycemia episodes. Her recent HbA1c is 8.5%, LDL cholesterol is 135 mg/dL, and urine microalbumin is 45 mg/dL. Considering her symptoms and lab results, which of the following nursing interventions is most appropriate to prioritize at this time?

B) Educate the patient on the importance of consistent blood glucose monitoring and consider the use of a continuous glucose monitor.

A) Advise the patient to increase physical activity to manage blood pressure and cholesterol levels.

B) Educate the patient on the importance of consistent blood glucose monitoring and consider the use of a continuous glucose monitor.

C) Recommend dietary modifications to reduce LDL cholesterol levels and improve glycemic control.

D) Schedule regular foot examinations to monitor for further sensory loss and prevent ulceration.

A patient with a recent diagnosis of mild ischemia and coronary artery disease is adjusting her insulin regimen due to frequent nocturnal hypoglycemia. Which nursing intervention is most appropriate to help reduce her risk of hypoglycemia while managing her cardiovascular health?

B) Collaborate with the healthcare provider to adjust the timing of insulin administration to align with her activity level.

A) Educate the patient on increasing carbohydrate intake before bed to prevent nocturnal hypoglycemia.

B) Collaborate with the healthcare provider to adjust the timing of insulin administration to align with her activity level.

C) Advise the patient to engage in vigorous exercise daily to improve cardiovascular function.

D) Suggest the patient take her long-acting insulin dose in the morning instead of at night to prevent hypoglycemia.

A patient with a history of coronary artery disease and diabetes has been started on an ACE inhibitor due to elevated blood pressure and rising urine microalbumin levels. The patient is also experiencing frequent nocturnal hypoglycemia. Which nursing action is most appropriate to address both the patient's cardiac and glycemic needs?

C) Collaborate with the healthcare team to adjust the patient's long-acting insulin dose and evaluate the need for additional cardiac medications.

A) Educate the patient about increasing her bedtime carbohydrate intake to prevent nocturnal hypoglycemia.

B) Instruct the patient to monitor her blood pressure closely and report any significant changes to her healthcare provider.

C) Collaborate with the healthcare team to adjust the patient's long-acting insulin dose and evaluate the need for additional cardiac medications.

D) Encourage the patient to increase her physical activity levels immediately to enhance cardiovascular health and improve glycemic control.

A patient with type 2 diabetes is experiencing new onset peripheral neuropathy despite improved glycemic control. Which intervention should the nurse prioritize to address the patient's symptoms and prevent further complications?

B) Instruct the patient on daily foot care and monitoring.

A) Encourage increased physical activity to improve circulation.

B) Instruct the patient on daily foot care and monitoring.

C) Recommend dietary changes to further reduce blood glucose levels.

D) Advise the patient to increase their ACE inhibitor dosage.

A patient with type 2 diabetes has shown improvement in blood pressure and glycemic control after the introduction of an ACE inhibitor and dietary changes. However, she now presents with new-onset peripheral neuropathy symptoms. Which intervention should the nurse prioritize to address the patient's current condition and prevent further complications?

A) Educate the patient on proper foot care and daily foot inspections.

B) Increase the dosage of the ACE inhibitor to improve circulation.

C) Recommend the patient to increase her physical activity to enhance glycemic control.

D) Suggest the patient to take over-the-counter pain relief for neuropathy symptoms.

A patient with type 2 diabetes mellitus has been started on a GLP-1 receptor agonist and a statin. Four weeks into the treatment, she reports improved neuropathy symptoms and weight loss. Her LDL cholesterol has decreased, and her hemoglobin A1c is 7.3%. However, she has developed mild diabetic retinopathy. What is the most appropriate nursing intervention to address this new complication?

B) Educate the patient on the importance of regular ophthalmologic assessments and maintaining optimal blood pressure and lipid levels.

A) Increase the dosage of the GLP-1 receptor agonist to better control blood glucose.

B) Educate the patient on the importance of regular ophthalmologic assessments and maintaining optimal blood pressure and lipid levels.

C) Discontinue the statin due to its potential side effects on the eyes.

D) Recommend immediate surgical intervention to treat diabetic retinopathy.

A patient with type 2 diabetes has shown improvement in glycemic control and a decrease in LDL cholesterol after starting a GLP-1 receptor agonist and statin. However, new findings indicate mild diabetic retinopathy. Which nursing intervention is most appropriate to prioritize at this time?

B) Educate the patient on the importance of regular eye examinations to monitor retinopathy progression.

A) Increase the frequency of blood glucose monitoring to detect hyperglycemic episodes.

B) Educate the patient on the importance of regular eye examinations to monitor retinopathy progression.

C) Recommend discontinuing the statin to eliminate potential side effects impacting the eyes.

D) Encourage the patient to reduce physical activity to prevent further eye damage.

Diabetes - Nursing Case Study

Pathophysiology

• Primary mechanism: Insulin resistance in peripheral tissues leads to impaired glucose uptake, causing elevated blood glucose levels. The body compensates by producing more insulin, eventually exhausting pancreatic beta cells.

• Secondary mechanism: Dysfunctional pancreatic beta cells reduce insulin secretion over time, exacerbating hyperglycemia. This is often due to genetic factors, chronic inflammation, or glucotoxicity.

• Key complication: Chronic hyperglycemia damages blood vessels, leading to complications like nephropathy, neuropathy, and retinopathy, significantly impacting patient quality of life and increasing healthcare needs.

Patient Profile

Demographics:

52-year-old female, office administrator

History:

• Key past medical history: Type 2 Diabetes Mellitus diagnosed 8 years ago, hypertension, hyperlipidemia

• Current medications: Metformin 1000 mg twice daily, Lisinopril 20 mg daily, Atorvastatin 40 mg daily, Aspirin 81 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and numbness in feet

• Key symptoms: Blurred vision, frequent urination, increased thirst, tingling in extremities

• Vital signs: Blood pressure 148/92 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, blood glucose 210 mg/dL

Section 1

As the clinical team conducts an initial assessment, they focus on the patient's chief complaint of increasing fatigue and numbness in her feet. These symptoms, combined with her blurred vision, frequent urination, and increased thirst, raise concerns about diabetic neuropathy and possibly retinopathy. A physical examination reveals decreased sensation in the distal extremities, particularly the feet, confirmed by monofilament testing. Additionally, fundoscopy shows signs of non-proliferative diabetic retinopathy with microaneurysms and cotton wool spots. These findings suggest that the chronic hyperglycemia has started to significantly impact her peripheral nerves and retinal blood vessels.

To further evaluate her condition, the healthcare team orders a series of diagnostic tests. Her HbA1c returns elevated at 9.2%, indicating poor long-term glycemic control. A comprehensive metabolic panel reveals a slight increase in serum creatinine at 1.4 mg/dL, hinting at early diabetic nephropathy. A lipid panel shows LDL cholesterol levels at 140 mg/dL, despite current statin therapy, highlighting the need for more aggressive lipid management. Urine microalbumin is positive, further supporting the suspicion of early kidney involvement.

These findings underscore the importance of intensifying her diabetes management plan. The team discusses with the patient the need for lifestyle changes, including dietary modifications and increased physical activity, to help control her blood glucose levels. Consideration of adding a GLP-1 receptor agonist or SGLT2 inhibitor to her regimen is discussed to provide additional cardiovascular and renal protection. The clinical team plans to monitor her symptoms closely and follow up with additional testing to evaluate the progression of her microvascular complications. The case now hinges on her response to these interventions and whether they can effectively stabilize her condition and prevent further complications.

Section 2

Three months after initiating the intensified diabetes management plan, the patient returns for a follow-up visit. Her chief complaints now include persistent fatigue and intermittent chest discomfort, especially after exertion. She also reports experiencing more frequent episodes of hypoglycemia, which occur unexpectedly and have left her feeling anxious about maintaining her daily activities. The clinical team notes that her blood pressure has increased slightly to 142/88 mmHg, and her heart rate is 92 beats per minute. Upon examination, there are no acute distress signs, but her feet show further diminished sensation and new callous formation on the plantar aspect.

Laboratory results show a modest improvement in her HbA1c, now at 8.5%, suggesting some effectiveness of the new medication regimen. However, her LDL cholesterol remains elevated at 135 mg/dL, despite adjustments in her statin therapy. Repeat urine microalbumin levels have increased, with a result of 45 mg/dL, indicating progression of diabetic nephropathy. The team identifies a potential need for further cardiovascular evaluation given her chest discomfort and the possibility of worsening cardiac risk. An ECG is ordered, revealing nonspecific ST-segment changes that prompt a referral to a cardiologist for stress testing.

The patient's evolving condition highlights the interconnected nature of her diabetic complications. The clinical team must now weigh the benefits of further pharmacological adjustments against the need to address her cardiovascular risks. They discuss with the patient the importance of closely monitoring her blood glucose levels to prevent hypoglycemic episodes and consider the potential role of a continuous glucose monitor for better glycemic control. The next phase of her care will focus on refining her treatment plan to manage her cardiovascular health while continuing to address her diabetes-related complications.

Section 3

Two weeks following her referral to a cardiologist, the patient undergoes a stress echocardiogram, which reveals mild ischemia indicative of coronary artery disease. This finding correlates with her reported chest discomfort during exertion. Recognizing the increased cardiovascular risk, her healthcare team initiates a conversation about lifestyle modifications, including dietary adjustments and a structured exercise program tailored to her current capabilities. They also discuss the potential addition of an ACE inhibitor to address her elevated blood pressure and further protect her renal function, considering her rising urine microalbumin levels.

In the interim, the patient's anxiety about hypoglycemic episodes has prompted the adoption of a continuous glucose monitor (CGM). Initial data from the CGM shows frequent nocturnal hypoglycemia, presenting an opportunity to adjust her insulin regimen. This provides a clearer picture of her glycemic patterns, allowing for more precise insulin dosing. Adjustments include lowering her long-acting insulin dose and modifying her mealtime insulin to better match her carbohydrate intake, reducing hypoglycemic episodes.

As her care plan evolves, the team schedules regular follow-ups to closely monitor her cardiovascular health and glycemic control. The patient is encouraged to maintain open communication with her healthcare providers, especially if new symptoms arise or if her current symptoms worsen. The collaborative approach aims to empower the patient, ensuring she understands the rationale behind each adjustment and feels supported in managing her complex condition. This proactive management strategy underscores the importance of an integrated approach to care, addressing both her diabetes and associated cardiovascular risk factors to improve her overall health outcomes.

Section 4

As the management plan progresses, the patient returns for a follow-up appointment two months later. During the visit, the healthcare team conducts a comprehensive assessment to evaluate her response to the interventions and identify any new complications. Her blood pressure is measured at 130/85 mmHg, showing improvement since the introduction of the ACE inhibitor. However, her latest lipid profile reveals an LDL cholesterol level of 145 mg/dL, indicating the need for further cardiovascular risk reduction. Her hemoglobin A1c has decreased to 7.5%, suggesting better glycemic control, albeit with room for improvement.

Despite these positive trends, the patient reports new onset of peripheral neuropathy symptoms, including tingling and numbness in her feet, which have become more pronounced over the past month. This development raises concerns about her long-term glycemic control and prompts the healthcare team to consider additional strategies to manage her diabetes more effectively. The team discusses the potential benefits of introducing a GLP-1 receptor agonist to help with weight management and further optimize her blood sugar levels, while also considering the need for a statin to address her elevated LDL levels.

The patient's care plan is adjusted to incorporate these new medications, and she is referred to a podiatrist for a comprehensive foot exam to prevent further complications. Educational sessions are scheduled to reinforce the importance of daily foot care and regular monitoring for any changes. The team emphasizes the importance of adherence to the updated treatment regimen and encourages the patient to remain vigilant for any new or worsening symptoms. This approach reflects a nuanced understanding of her evolving condition, aiming to prevent further complications while enhancing her quality of life.

Section 5

As the healthcare team continues to monitor the patient's progress, they focus on her response to the newly introduced interventions, particularly the GLP-1 receptor agonist and statin. Four weeks into the updated regimen, the patient returns for a follow-up visit. She reports a slight improvement in her peripheral neuropathy symptoms, describing the tingling and numbness in her feet as less frequent and intense. This suggests a positive response to the enhanced glycemic control. Additionally, she has experienced weight loss of approximately 5 pounds, aligning with the weight management benefits of the GLP-1 receptor agonist. Her blood pressure remains stable at 128/83 mmHg, further supporting the effectiveness of the combined treatment plan.

However, new diagnostic results reveal a mixed picture. Her latest lipid profile shows a decrease in LDL cholesterol to 130 mg/dL, indicating that the statin is beginning to exert its intended effects. Her hemoglobin A1c has also decreased slightly to 7.3%, reflecting ongoing improvement in glycemic management. Despite these favorable trends, the patient has developed mild signs of diabetic retinopathy, discovered during a routine ophthalmologic examination. This finding underscores the complexity of diabetes management and the need for a comprehensive approach to prevent microvascular complications.

Given these developments, the healthcare team conducts a thorough review of the patient's overall condition and adjusts her care plan accordingly. They intensify their focus on preventing progression of retinopathy by ensuring optimal blood pressure, lipid, and blood glucose control. Regular ophthalmologic assessments are scheduled, and the patient is advised to maintain strict adherence to her prescribed regimen. The team also reinforces the importance of lifestyle modifications, including diet and exercise, to achieve additional improvements in her cardiovascular risk profile. This ongoing, multifaceted strategy aims to mitigate existing complications while preventing new ones, ultimately enhancing the patient's long-term health and quality of life.